Xerostomia Secondary to Sjögren’s Syndrome in the ElderlyRecognition and Management

被引:0
|
作者
Ibtisam Al-Hashimi
机构
[1] Baylor College of Dentistry,Department of Periodontics, Salivary Dysfunction Clinic
[2] University of Texas Southwestern Medical Center,Department of Surgery, Division of Oral Surgery
[3] Baylor College of Dentistry,undefined
来源
Drugs & Aging | 2005年 / 22卷
关键词
Salivary Gland; Oral Health; Salivary Flow; Exocrine Gland; Salivary Flow Rate;
D O I
暂无
中图分类号
学科分类号
摘要
Xerostomia is a common symptom in the elderly population. Studies have suggested that the underlying cause of approximately 40% of xerostomia in the elderly is Sjögren’s syndrome. Although it is highly prevalent among middle-aged individuals, elderly patients account for up to 20% of Sjögren’s syndrome cases. Sjögren’s syndrome is a multisystem exocrinopathy characterised by dry mouth and dry eyes with wide-ranging extraglandular involvement. The exocrine manifestations of Sjögren’s syndrome affect the mouth, eyes, nose, ears, skin, vagina and the entire respiratory and gastrointestinal systems. The nonexocrine involvement may include the joints, thyroid gland, liver, kidneys and the musculoskeletal, vascular and central nervous systems. Currently, the mechanism(s) of development and progression of Sjögren’s syndrome is/are not clear. Inflammation and lymphocytic infiltration of the exocrine glands is a classical feature of Sjögren’s syndrome. During the progression of the disease, the acinar cells of the exocrine glands are replaced by fibrosis, rendering the glands nonfunctional. Sjögren’s syndrome remains one of the most underdiagnosed conditions, particularly in the elderly population, because the cardinal sicca symptoms, which are the hallmark of the disease, are frequently attributed to aging and/or medications, which consequently delays the diagnosis. This delay in diagnosis imposes significant physical, psychological and economic burdens on elderly patients. The diagnosis of Sjögren’s syndrome requires evaluation of both the exocrine and nonexocrine components of the disease. Management of Sjögren’s syndrome requires collaboration by the primary-care physician, rheumatologist, ophthalmologist and dentist. This article reviews current understanding of the clinical manifestations, diagnosis and treatment of Sjögren’s syndrome with special emphasis on the oral component of the disease.
引用
收藏
页码:887 / 899
页数:12
相关论文
共 50 条
  • [1] Muscarinics for Xerostomia in Patients with Sjögren’s Syndrome
    Martin M. Ferguson
    Clinical Drug Investigation, 2002, 22 (9) : 639 - 640
  • [2] The management of Sjögren's syndrome
    Clio P Mavragani
    Niki M Moutsopoulos
    Haralampos M Moutsopoulos
    Nature Clinical Practice Rheumatology, 2006, 2 : 252 - 261
  • [4] Use of Rituximab in the Management of Sjögren’s Syndrome
    Francesco Carubbi
    Alessia Alunno
    Paola Cipriani
    Onorina Berardicurti
    Piero Ruscitti
    Vasiliki Liakouli
    Francesco Ciccia
    Giovanni Triolo
    Roberto Gerli
    Roberto Giacomelli
    Current Treatment Options in Rheumatology, 2015, 1 (3) : 277 - 291
  • [5] Management of Dry Eye in Sjögren’s Syndrome
    Michelle Hessen
    Sezen Karakus
    Esen Karamursel Akpek
    Current Treatment Options in Rheumatology, 2015, 1 (3) : 292 - 304
  • [6] Esophageal Motor Function in Primary Sjögren's Syndrome Correlation with Dysphagia and Xerostomia
    Marco Anselmino
    Giovanni Zaninotto
    Mario Costantini
    Pierantonio Ostuni
    Aurora Ianniello
    Chiara Boccu
    Andrea Doria
    Silvano Todesco
    Ermanno Ancona
    Digestive Diseases and Sciences, 1997, 42 : 113 - 118
  • [7] Sjögren’s syndrome
    Geza Balint
    W. Watson Buchanan
    Colin A. Kean
    Walter Kean
    K. D. Rainsford
    Inflammopharmacology, 2024, 32 : 37 - 43
  • [8] Sjögren’s Syndrome in Older PatientsAetiology, Diagnosis and Management
    Rada V. Moerman
    Hendrika Bootsma
    Frans G. M. Kroese
    Arjan Vissink
    Drugs & Aging, 2013, 30 : 137 - 153
  • [9] Sjögren-SyndromSjögren’s syndrome
    Torsten Witte
    Zeitschrift für Rheumatologie, 2019, 78 : 511 - 517
  • [10] Sjögren-SyndromSjögren’s syndrome
    T. Witte
    Zeitschrift für Rheumatologie, 2014, 73 : 49 - 61